Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
- PMID: 9708402
- DOI: 10.1097/00002030-199811000-00004
Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
Abstract
Objective: To evaluate immune reconstitution within HIV-infected lymphoid tissue during highly active antiretroviral therapy (HAART).
Design and methods: In situ cellular responses were studied in sequential tonsillar biopsies in three asymptomatic HIV-infected (CD4 cells greater than 400 x 10(6)/l) antiretroviral treatment-naive volunteers enrolled in a clinical trial to determine the early effect of HAART. Computerized image analysis was used to study immunohistochemically stained sequential tonsil sections for the patterns of local cytokine production, chemokine receptor expression and cellular distribution. Replicate quantitative assessments of samples before and after 4 weeks of therapy were used for the evaluation of drug effects and compared with four uninfected controls. Tonsillar HIV proviral-DNA was determined by fluorescent in situ 5'-nuclease assay.
Results: HIV-infected tonsil tissue was characterized by extensive pro-inflammatory and type 1 cytokine expression. A five- to 15-fold elevation of interleukin (IL)-1 alpha, IL-12, IL-2 and interferon (IFN)-gamma protein expression was found compared with controls, and each encompassed a mean of at least 4.5% of the tissue compartment. This was reduced by 20-90% in all individuals after 4 weeks of HAART. In contrast, type 2 cytokine expression (IL-4, IL-10), plus tumour necrosis factor (TNF)-alpha, remained low throughout the study. HAART reduced, by 40%, the expression of HIV co-receptors, CCR5 and CXCR4, which initially were elevated four to six times over the control values. In addition, the myelomonocytic inflammatory proteins, CD68 and calprotectin, diminished by 26-83% after therapy. The HIV RNA was reduced to undetectable levels in plasma by HAART. However, a large pool of tonsil cells (2-7%), remained HIV DNA positive after 4 weeks of therapy.
Conclusions: Although immune activation may be the direct consequence of HIV replication, HAART-associated reconstitution begins with a reduction in inflammatory cytokine production which precedes the elimination of local proviral reservoirs.
Similar articles
-
CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.Clin Exp Immunol. 1999 Oct;118(1):87-94. doi: 10.1046/j.1365-2249.1999.01033.x. Clin Exp Immunol. 1999. PMID: 10540164 Free PMC article.
-
Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy.J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):150-6. doi: 10.1097/00042560-200010010-00009. J Acquir Immune Defic Syndr. 2000. PMID: 11103045
-
Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2.Clin Exp Immunol. 1999 Jun;116(3):486-92. doi: 10.1046/j.1365-2249.1999.00927.x. Clin Exp Immunol. 1999. PMID: 10361239 Free PMC article. Clinical Trial.
-
Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.AIDS Res Hum Retroviruses. 2000 Feb 10;16(3):191-201. doi: 10.1089/088922200309287. AIDS Res Hum Retroviruses. 2000. PMID: 10710207
-
[Deep lung--cellular reaction to HIV].Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese.
Cited by
-
Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors.AIDS. 2012 Sep 24;26(15):1879-84. doi: 10.1097/QAD.0b013e328357f5d1. AIDS. 2012. PMID: 22824629 Free PMC article.
-
Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection.Am J Pathol. 2000 Jun;156(6):1973-86. doi: 10.1016/S0002-9440(10)65070-5. Am J Pathol. 2000. PMID: 10854220 Free PMC article. Clinical Trial.
-
Parallel studies of mucosal immunity in the reproductive and gastrointestinal mucosa of HIV-infected women.Am J Reprod Immunol. 2020 Jul;84(1):e13246. doi: 10.1111/aji.13246. Epub 2020 May 8. Am J Reprod Immunol. 2020. PMID: 32301548 Free PMC article.
-
The lymph node in HIV pathogenesis.Semin Immunol. 2008 Jun;20(3):187-95. doi: 10.1016/j.smim.2008.06.001. Epub 2008 Jul 14. Semin Immunol. 2008. PMID: 18620868 Free PMC article. Review.
-
Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa.Front Immunol. 2019 Mar 8;10:426. doi: 10.3389/fimmu.2019.00426. eCollection 2019. Front Immunol. 2019. PMID: 30906299 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials